Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02349555 · ClinicalTrials.gov registry record · NA
Nutritional Supplement Impact on Metabolic Parameters
A NA study, sponsored by Pharmanex.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02349555: Completed NA study, sponsored by Pharmanex.
NCT02349555 is a NA study that has completed, run by Pharmanex. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02349555, a NA study, has completed, sponsored by Pharmanex.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This open label study seeks to study the effects of a nutritional supplement on inflammatory markers, metabolic parameters, and safety in subjects compared to baseline after taking supplement for 2 and 4 months.
Interventions
- DIETARY_SUPPLEMENT Nutritional Supplement Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02349555 record still lists
NCT02349555 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Nutritional Supplement Blend is the first listed.
NCT02349555 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02349555 about?
NCT02349555 is a clinical study titled "Nutritional Supplement Impact on Metabolic Parameters". This open label study seeks to study the effects of a nutritional supplement on inflammatory markers, metabolic parameters, and safety in subjects compared to baseline after taking supplement for 2 and 4 months.
What is the current status of trial NCT02349555?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-01. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02349555?
The interventions under investigation include: Nutritional Supplement Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02349555?
This trial is sponsored by Pharmanex, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02349555's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia